Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUAAAL dual RAS blockade in non-diabetic proteinuric renal disease
NL-OMON23057Recruiting
- Sponsor
- Novartis
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lisinopril and valsartan in proteinuria and chronic kidney disease (CKD) (2 arms), sponsored by Novartis. Primary endpoints: Reduction in proteinuria and Reduction in blood pressure. Started Apr 2006; status: recruiting.
02
Drugs
lisinoprilvalsartan
03
Conditions
proteinuriachronic kidney disease (CKD)
Beyond the preview
Go deeper on NL-OMON23057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23057.